April 14, 2026
Parexel received 2026 Triangle Business Journal Life Sciences Award – Most Innovative Clinical Research Organization

Parexel received a 2026 Triangle Business Journal (TBJ) Life Sciences Award in the Most Innovative Clinical Research Organization (CRO) category. These awards recognize individuals and organizations advancing innovation across the life sciences, including biotechnology, pharmaceuticals, clinical research, medical devices, diagnostics and human health. Parexel was recognized for our industry-leading clinical development impact, combining regulatory leadership, therapeutic expertise, AI driven innovation and meaningful Triangle community leadership that advances biomedical R&D.

March 11, 2026
Parexel received 2026 NEXT Award for Patient Leadership from Medidata

Parexel was named the winner of the 2026 NEXT Award for Patient Leadership from Medidata Solutions. This award recognizes Parexel’s commitment to patient-focused technology and patient insights to improve the clinical trial experience and decrease burden on trial participants. Award winners were recognized at Medidata NEXT in NYC on March 11.

February 23, 2026
Parexel named one of Newsweek's "America's Greatest Workplaces for Culture, Belonging & Community 2026"

Parexel was named one of Newsweek's "America's Greatest Workplaces for Culture, Belonging & Community 2026," recognizing companies that have made an inclusive workplace environment the foundation of their organizational success. This comprehensive ranking evaluates U.S. employers with more than 1,000 employees based on their performance across metrics that matter most to women, minorities and diverse demographic groups.

February 19, 2026
Parexel received Triangle Business Journal's 2026 Space Award

Parexel was recognized with the Triangle Business Journal's 2026 Space Award for Top Interior Space/Build-Out Project for our new global headquarters in Raleigh's North Hills Innovation District (NHID). The Triangle Business Journal's Space Awards honor the Triangle market's top commercial real estate deals and developments.

February 4, 2026
Parexel recognized in Human Rights Campaign Foundation's 2026 Corporate Equality Index

Parexel was recognized in the Human Rights Campaign Foundation’s 2026 Corporate Equality Index for our commitment to LGBTQ+ equality and inclusion. The recognition – with a five-point score increase from the previous year – reflects the dedication of our Global Inclusion team’s leadership, advocacy of our Parexel Pride business resource group, and commitment of our global colleagues who champion inclusion every day. The Human Rights Campaign Foundation’s State of the Workplace for LGBTQ+ Americans and Corporate Equality Index 2026 provides a research-based snapshot of LGBTQ+ experiences in U.S. workplaces and a national benchmark of corporate policies, practices, and benefits pertinent to LGBTQ+ employees.

January 7, 2026
Parexel recognized by Carbon Disclosure Project

Parexel was recognized for its participation and transparency on environmental issues and sustainability by CDP, a global environmental non-profit that runs the world’s only independent disclosure system. Parexel has disclosed to CDP for the past 12 years. CDP is fully aligned with the Task Force on Climate Related Financial Disclosures (TCFD) framework and maintains the world’s largest repository of environmental data. Its scoring system is widely used by investors and procurement teams seeking to accelerate progress towards a net-zero, sustainable and earth-positive global economy.